Researchers urge more studies on off-label use of 14 drugs

11/24/2008 | HealthDay News

Fourteen broadly prescribed medicines, including the psychiatric drug Seroquel and the blood thinner warfarin, need to be studied further to test their safety and efficacy for unapproved applications, according to a U.S. study. The lead researcher did not recommend against off-label prescription but said authorities should step up efforts to monitor the practice.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC